Live feed
·
INSIDERFilingvia Quantisnow
Instil Bio Inc. logo

Instil Bio (TIL) director McGaughy received 1,500 Stock Option (Right to Buy)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

R Kent McGaughy Jr (director at Instil Bio Inc., TIL) reported that they received 1,500 Stock Option (Right to Buy) on Jun 14, 2023.

Reporting person
McGaughy R Kent Jr

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 14, 2023Grant or award (A)Stock Option (Right to Buy)On 1,500 Common Stock1+1,500--1,500 direct

Holdings before and after

  • Stock Option (Right to Buy): 0 to 1,500 direct

Footnotes from the filing

  1. 1. The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did McGaughy report in this TIL Form 4?

R Kent McGaughy Jr (director at Instil Bio Inc., TIL) reported that they received 1,500 Stock Option (Right to Buy) on Jun 14, 2023.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for TIL

Earlier insider filings at TIL

Quantisnow market dataNASDAQ
Instil Bio Inc. logo
TIL
Instil Bio Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2021
Get push alerts for TIL

Follow TIL and get a push notification the moment its next story breaks.

Full TIL profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TIL (Instil Bio Inc.) and more on Quantisnow.